Physiomics (LON:PYC) Stock Price Down 12.8% – Should You Sell?

Physiomics Plc (LON:PYCGet Free Report)’s stock price dropped 12.8% during trading on Wednesday . The company traded as low as GBX 0.46 and last traded at GBX 0.46. 1,043,813 shares were traded during trading, a decline of 86% from the average daily volume of 7,213,239 shares. The stock had previously closed at GBX 0.53.

Physiomics Trading Down 2.3%

The company has a market cap of £2.10 million, a price-to-earnings ratio of -3.09 and a beta of 1.02. The firm has a 50-day moving average price of GBX 0.55 and a 200 day moving average price of GBX 0.45.

About Physiomics

(Get Free Report)

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Further Reading

Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.